Actinomycin D treatment

LV Linda Vidarsdottir
RF Rita Valador Fernandes
VZ Vasilios Zachariadis
ID Ishani Das
EE Elin Edsbäcker
IS Ingibjorg Sigvaldadottir
AA Alireza Azimi
VH Veronica Höiom
JH Johan Hansson
DG Dan Grandér
SB Suzanne Egyházi Brage
KT Katja Pokrovskaja Tamm
ask Ask a question
Favorite

A375PR1 cells were treated with 8 µg/ml actinomycin D (Sigma-Aldrich, saint Louis, Missouri, USA) and RNA was harvested at different time points (0, 2, 6 and 10 h) followed by cDNA synthesis and reverse transcription quantitative PCR (RT-qPCR). Primers are listed in Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/MR/A233.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A